Form 4: Alignment Healthcare Exec Acquires Stock Units

Joseph S. Konowiecki, EVP Corporate Affairs and Director at Alignment Healthcare, Inc., acquired 122,807 restricted stock units on June 3, 2026.

Summary

• Joseph S. Konowiecki, who holds the positions of EVP, Corporate Affairs and Director at Alignment Healthcare, Inc., acquired 122,807 restricted stock units (RSUs) on June 3, 2026.
• These RSUs represent the right to receive one share of Common Stock of Alignment Healthcare, Inc. per unit.
• The RSUs are scheduled to vest in approximately one-third increments on March 13, 2027, March 13, 2028, and March 13, 2029, contingent upon Konowiecki's continued service to the company.
• Following this transaction, Konowiecki beneficially owns 1,203,816 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant strategic or financial development.

Positives

• The acquisition of restricted stock units by a key executive like Joseph S. Konowiecki can signal confidence in the company's future prospects.
• The vesting schedule over three years suggests a long-term commitment from the executive to the company's success.
• The executive's continued beneficial ownership of over 1.2 million shares indicates a significant personal stake in the company.

Negatives

• The filing does not disclose the purchase price, but the acquisition of RSUs at $0 suggests they were granted as compensation rather than purchased on the open market.
• The vesting is contingent on continued service, meaning the executive could leave before fully realizing the value of the RSUs.

Risks

• The value of the restricted stock units is subject to the future performance of Alignment Healthcare, Inc.'s stock price.
• The continued service requirement for vesting means that if the reporting person departs the company before the vesting dates, the unvested RSUs will be forfeited.

Future Outlook

The future outlook for the acquired restricted stock units is tied to the company's performance, with vesting scheduled over the next three years, contingent on continued service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of equity awards like restricted stock units by senior management and directors, are common in the healthcare and technology sectors as a method of executive compensation and long-term incentive alignment.

Stakeholder Impact

• Shareholders: The transaction itself is a standard compensation practice and does not immediately impact share price, but the executive's continued stake may be viewed positively.
• Employees: The executive's long-term incentive aligns with company performance, potentially benefiting employees through overall company success.
• Management: Reinforces the use of equity-based compensation for executive retention and motivation.

Next Steps

• Continued service by Joseph S. Konowiecki to meet vesting requirements for the restricted stock units.
• Vesting of restricted stock units on March 13, 2027, March 13, 2028, and March 13, 2029.

Key Dates

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Joseph S. Konowiecki